Fatty acid epoxyisoprostane E2 stimulates an oxidative stress response in endothelial cells

Biochemical and Biophysical Research Communications

Volumn 444, Issue 1, 2014, Pages 69-74

  Yan, Xinmin ^a   Lee, Sangderk ^b   Gugiu, B Gabriel ^c   Koroniak, Lukasz ^b   Jung, Michael E ^b   Berliner, Judith ^b   Cheng, Jinluo ^a,d   Li, Rongsong ^b,d  

^a THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d University of Southern California ^*  (United States)

Author keywords

Epoxyisoprostane E2 (EI); HO 1 oxidative stress; Nrf2; OKL38; Oxidized phospholipids; OxPAPC

Indexed keywords

1 PALMITOYL 2 ARACHIDONOYL SN GLYCERO 3 PHOSPHORYLCHOLINE; ACETYLCYSTEINE; APOCYNIN; EPOXYISOPROSTANE E2; FATTY ACID; HEME OXYGENASE 1; PHOSPHOLIPID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EPOXYISOPROSTANE E2 (EI); HO-1 OXIDATIVE STRESS; NRF2; OKL38; OXIDIZED PHOSPHOLIPIDS; OXPAPC;

ATHEROSCLEROSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; HEME OXYGENASE-1; HUMANS; ISOPROSTANES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84893829477     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.016     Document Type: Article

References (35)

1. S. Lee, K.G. Birukov, C.E. Romanoski, J.R. Springstead, A.J. Lusis, and J.A. Berliner Role of phospholipid oxidation products in atherosclerosis Circ. Res. 111 2012 778 799
2. J.A. Berliner, N. Leitinger, and S. Tsimikas The role of oxidized phospholipids in atherosclerosis J. Lipid Res. 50 Suppl. 2009 S207 S212
3. J.A. Berliner, G. Subbanagounder, N. Leitinger, A.D. Watson, and D. Vora Evidence for a role of phospholipid oxidation products in atherogenesis Trends Cardiovasc. Med. 11 2001 142 147 (Pubitemid 33070338)
4. N. Leitinger Oxidized phospholipids as modulators of inflammation in atherosclerosis Curr. Opin. Lipidol. 14 2003 421 430 (Pubitemid 37297296)
5. R.S. Rosenson, and E. Hurt-Camejo Phospholipase A2 enzymes and the risk of atherosclerosis Eur. Heart J. 33 2012 2899 2909
6. S. Imaizumi, V. Grijalva, M. Navab, B.J. Van Lenten, A.C. Wagner, G.M. Anantharamiah, A.M. Fogelman, and S.T. Reddy L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice Drug Metab. Lett. 4 2010 139 148
7. C. Morgantini, A. Natali, B. Boldrini, S. Imaizumi, M. Navab, A.M. Fogelman, E. Ferrannini, and S.T. Reddy Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Diabetes 60 2011 2617 2623
8. C.D. Funk, and T. Cyrus 12/15-Lipoxygenase, oxidative modification of LDL and atherogenesis Trends Cardiovasc. Med. 11 2001 116 124 (Pubitemid 33070334)
9. G. Subbanagounder, N. Leitinger, D.C. Schwenke, J.W. Wong, H. Lee, C. Rizza, A.D. Watson, K.F. Faull, A.M. Fogelman, and J.A. Berliner Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position Arterioscler., Thromb., Vasc. Biol. 20 2000 2248 2254
10. G. Subbanagounder, J.W. Wong, H. Lee, K.F. Faull, E. Miller, J.L. Witztum, and J.A. Berliner Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta J. Biol. Chem. 277 2002 7271 7281 (Pubitemid 34953120)
11. A.D. Watson, G. Subbanagounder, D.S. Welsbie, K.F. Faull, M. Navab, M.E. Jung, A.M. Fogelman, and J.A. Berliner Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein J. Biol. Chem. 274 1999 24787 24798
12. W. Zhong, J.R. Springstead, R. Al-Mubarak, S. Lee, R. Li, B. Emert, J.A. Berliner, and M.E. Jung An epoxyisoprostane is a major regulator of endothelial cell function J. Med. Chem. 56 2013 8521 8532 10.1021/jm400959q
13. R. Li, W. Chen, R. Yanes, S. Lee, and J.A. Berliner OKL38 is an oxidative stress response gene stimulated by oxidized phospholipids J. Lipid Res. 48 2007 709 715 (Pubitemid 46397474)
14. M.E. Jung, J.A. Berliner, D. Angst, D. Yue, L. Koroniak, A.D. Watson, and R. Li Total synthesis of the epoxy isoprostane phospholipids PEIPC and PECPC Org. Lett. 7 2005 3933 3935 (Pubitemid 41305678)
15. M.E. Jung, J.A. Berliner, L. Koroniak, B.G. Gugiu, and A.D. Watson Improved synthesis of the epoxy isoprostane phospholipid PEIPC and its reactivity with amines Org. Lett. 10 2008 4207 4209
16. M.E. Jung, A. Kers, G. Subbanagounder, and J.A. Berliner Studies towards the total synthesis of an epoxy isoprostane phospholipid, a potent activator of endothelial cells Chem. Commun. (Cambridge, U.K.) 2 2003 196 197 (Pubitemid 36132018)
17. A.L. Cole, G. Subbanagounder, S. Mukhopadhyay, J.A. Berliner, and D.K. Vora Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/PI3-kinase pathway Arterioscler., Thromb., Vasc. Biol. 23 2003 1384 1390 (Pubitemid 36994526)
18. R. Li, K.P. Mouillesseaux, D. Montoya, D. Cruz, N. Gharavi, M. Dun, L. Koroniak, and J.A. Berliner Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC Circ. Res. 98 2006 642 650
19. L. Osborn, S. Kunkel, and G.J. Nabel Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B Proc. Natl. Acad. Sci. U S A 86 1989 2336 2340 (Pubitemid 19102503)
20. M. Yeh, N.M. Gharavi, J. Choi, X. Hsieh, E. Reed, K.P. Mouillesseaux, A.L. Cole, S.T. Reddy, and J.A. Berliner Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway J. Biol. Chem. 279 2004 30175 30181 (Pubitemid 38937941)
21. T. Munzel, I.B. Afanas'ev, A.L. Kleschyov, and D.G. Harrison Detection of superoxide in vascular tissue Arterioscler., Thromb., Vasc. Biol. 22 2002 1761 1768 (Pubitemid 35315760)
22. S. Lee, N.M. Gharavi, H. Honda, I. Chang, B. Kim, N. Jen, R. Li, A. Zimman, and J.A. Berliner A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids Free Radical Biol. Med. 47 2009 145 151
23. P.S. Gargalovic, N.M. Gharavi, M.J. Clark, J. Pagnon, W.P. Yang, A. He, A. Truong, T. Baruch-Oren, J.A. Berliner, T.G. Kirchgessner, and A.J. Lusis The unfolded protein response is an important regulator of inflammatory genes in endothelial cells Arterioscler., Thromb., Vasc. Biol. 26 2006 2490 2496 (Pubitemid 44607470)
24. P.S. Gargalovic, M. Imura, B. Zhang, N.M. Gharavi, M.J. Clark, J. Pagnon, W.P. Yang, A. He, A. Truong, S. Patel, S.F. Nelson, S. Horvath, J.A. Berliner, T.G. Kirchgessner, and A.J. Lusis Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids Proc. Natl. Acad. Sci. U S A 103 2006 12741 12746 (Pubitemid 44298631)
25. A. Zimman, K.P. Mouillesseaux, T. Le, N.M. Gharavi, A. Ryvkin, T.G. Graeber, T.T. Chen, A.D. Watson, and J.A. Berliner Vascular endothelial growth factor receptor 2 plays a role in the activation of aortic endothelial cells by oxidized phospholipids Arterioscler., Thromb., Vasc. Biol. 27 2007 332 338 (Pubitemid 46143048)
26. B.G. Gugiu, K. Mouillesseaux, V. Duong, T. Herzog, A. Hekimian, L. Koroniak, T.M. Vondriska, and A.D. Watson Protein targets of oxidized phospholipids in endothelial cells J. Lipid Res. 49 2008 510 520
27. J.R. Springstead, B.G. Gugiu, S. Lee, S. Cha, A.D. Watson, and J.A. Berliner Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function J. Lipid Res. 53 2012 1304 1315
28. S. Lee, J.R. Springstead, B.W. Parks, C.E. Romanoski, R. Palvolgyi, T. Ho, P. Nguyen, A.J. Lusis, and J.A. Berliner Metalloproteinase processing of HBEGF is a proximal event in the response of human aortic endothelial cells to oxidized phospholipids Arterioscler., Thromb., Vasc. Biol. 32 2012 1246 1254
29. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86 (Pubitemid 28079219)
30. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82 (Pubitemid 28079218)
31. A. Rossi, P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M.G. Santoro Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase Nature 403 2000 103 108 (Pubitemid 30038530)
32. E. Kansanen, A.M. Kivela, and A.L. Levonen Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2 Free Radical Biol. Med. 47 2009 1310 1317
33. S. Lee, R. Li, B. Kim, R. Palvolgyi, T. Ho, Q.Z. Yang, J. Xu, W.L. Szeto, H. Honda, and J.A. Berliner Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell J. Lipid Res. 50 2009 265 274
34. G. Kronke, V.N. Bochkov, J. Huber, F. Gruber, S. Bluml, A. Furnkranz, A. Kadl, B.R. Binder, and N. Leitinger Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein J. Biol. Chem. 278 2003 51006 51014 (Pubitemid 38020334)
35. G. Kronke, A. Kadl, E. Ikonomu, S. Bluml, A. Furnkranz, I.J. Sarembock, V.N. Bochkov, M. Exner, B.R. Binder, and N. Leitinger Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors Arterioscler., Thromb., Vasc. Biol. 27 2007 1276 1282 (Pubitemid 46809415)